Loading…
Kanoria Chemicals & Industries (KANORICHEM)₹164.00−1.34%Industrial Products
In the Jun 2026 quarter (consolidated), Kanoria Chemicals & Industries reported sales of ₹460 Cr, up 128.9% from Jun 2025, and net profit of ₹25.90 Cr. For the year to Mar 2026, sales were ₹980 Cr and net profit ₹113 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 371 | 342 | 361 | 384 | 177 | 180 | 431 | 201 | 210 | 266 | 304 | 460 |
| Expenses | 364 | 338 | 332 | 380 | 176 | 164 | 413 | 182 | 203 | 245 | 276 | 413 |
| Operating Profit | 6.01 | 3.01 | 29.04 | 2.01 | 0.00 | 15.04 | 17.03 | 18.03 | 6.01 | 20.04 | 27.06 | 45.08 |
| OPM % | 1.6% | 0.8% | 8.0% | 0.5% | 0.1% | 8.0% | 3.9% | 9.0% | 3.0% | 7.0% | 9.0% | 10.0% |
| Other Income | 0.00 | 8.01 | 0.00 | 2.01 | 6.01 | −26.05 | −27.03 | −13.02 | 106 | 2.01 | 7.01 | 7.01 |
| Interest | 11.99 | 8.99 | 11.99 | 10.99 | 7.99 | 7.99 | 11.99 | 6.99 | 8.99 | 7.99 | 7.99 | 6.99 |
| Depreciation | 15.01 | 15.01 | 14.99 | 14.99 | 8.01 | 8.01 | 15.99 | 9.01 | 9.01 | 9.01 | 9.01 | 8.99 |
| Profit before tax | −20.97 | −12.98 | 1.99 | −21.96 | −8.98 | −26.95 | −37.91 | −9.98 | 94.86 | 5.99 | 16.96 | 34.91 |
| Tax % | −3.0% | 14.1% | 816.1% | 4.0% | 77.1% | 6.0% | 5.0% | 32.1% | 4.0% | 38.1% | −85.9% | 25.1% |
| Exceptional items | 0.00 | −0.99 | 0.00 | 0.99 | −5.99 | −26.94 | −27.93 | −12.97 | 93.85 | 0.00 | 0.00 | 0.00 |
| Net Profit | −20.93 | −14.95 | −15.95 | −22.93 | −15.95 | −28.90 | −39.89 | −13.96 | 91.69 | 3.99 | 31.91 | 25.90 |
| EPS (Rs) | −4.18 | −1.85 | −2.11 | −3.80 | −3.17 | −3.81 | −8.30 | −1.78 | 21.31 | 0.80 | 7.21 | 6.01 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 565 | 701 | 837 | 1,071 | 1,004 | 1,094 | 1,369 | 1,576 | 1,475 | 753 | 980 | 1,240 |
| Expenses | 531 | 673 | 799 | 1,004 | 974 | 997 | 1,297 | 1,502 | 1,417 | 720 | 906 | 1,138 |
| Operating Profit | 32.08 | 27.05 | 35.08 | 64.15 | 28.05 | 94.19 | 68.15 | 72.17 | 52.08 | 33.07 | 71.16 | 98.19 |
| OPM % | 6.0% | 3.8% | 4.1% | 6.0% | 2.8% | 9.0% | 5.0% | 4.6% | 3.5% | 4.3% | 7.0% | 7.9% |
| Other Income | 15.03 | 7.01 | 45.09 | 7.01 | 22.04 | 8.01 | 29.05 | 10.01 | 16.02 | −66.08 | 103 | 122 |
| Interest | 13.99 | 19.99 | 23.97 | 36.01 | 36.99 | 32.01 | 26.98 | 35.97 | 42.99 | 30.99 | 31.99 | 31.96 |
| Depreciation | 33.99 | 45.03 | 47.03 | 49.03 | 55.99 | 58.01 | 57.04 | 59.01 | 58.99 | 31.99 | 35.02 | 36.02 |
| Profit before tax | −0.99 | −31.95 | 9.99 | −14.97 | −42.90 | 10.97 | 12.98 | −11.98 | −33.94 | −96.77 | 107 | 153 |
| Tax % | 414.1% | −25.0% | −19.9% | 30.1% | −25.9% | −39.9% | 83.1% | 5.0% | 61.1% | 12.1% | −5.0% | — |
| Exceptional items | 0.99 | −16.97 | 1.99 | −2.99 | 0.00 | −3.99 | 0.00 | 9.98 | 1.99 | −22.94 | 0.00 | 93.85 |
| Net Profit | −6.97 | −23.92 | 11.96 | −19.95 | −31.89 | 15.93 | 1.99 | −12.95 | −54.84 | −108 | 113 | 153 |
| EPS (Rs) | −1.64 | −3.37 | 3.21 | −3.41 | −5.88 | 3.31 | 1.55 | −2.00 | −8.76 | −19.06 | 27.54 | 35.33 |
| Dividend payout % | −91.0% | −44.0% | 47.0% | −22.0% | 0.0% | 0.0% | 64.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22.06 | 22.05 | 22.07 | 22.07 | 22.06 | 22.08 | 22.08 | 22.07 | 22.06 | 22.06 | 22.08 | 22.07 |
| Reserves | 473 | 582 | 559 | 568 | 578 | 549 | 567 | 578 | 586 | 580 | 501 | 553 |
| Borrowings | 332 | 431 | 409 | 441 | 510 | 541 | 495 | 476 | 511 | 510 | 597 | 292 |
| Other Liabilities | 158 | 193 | 223 | 251 | 294 | 267 | 283 | 331 | 368 | 382 | 384 | 254 |
| Total Liabilities | 984 | 1,228 | 1,213 | 1,282 | 1,405 | 1,379 | 1,367 | 1,407 | 1,486 | 1,494 | 1,504 | 1,121 |
| Fixed Assets | 345 | 514 | 745 | 803 | 852 | 897 | 867 | 865 | 885 | 853 | 868 | 730 |
| CWIP | 181 | 268 | 26.94 | 11.97 | 41.87 | 14.96 | 13.96 | 9.97 | 9.97 | 46.89 | 45.87 | 31.93 |
| Investments | 175 | 138 | 100 | 63.18 | 48.15 | 26.06 | 19.05 | 22.08 | 17.04 | 16.03 | 14.03 | 59.17 |
| Other Assets | 283 | 307 | 341 | 404 | 463 | 441 | 467 | 509 | 575 | 580 | 577 | 300 |
| Inventories | 75.85 | 79.79 | 103 | 141 | 190 | 181 | 167 | 253 | 277 | 285 | 245 | 106 |
| Trade receivables | 74.68 | 87.62 | 113 | 138 | 145 | 143 | 202 | 172 | 195 | 185 | 237 | 133 |
| Cash & equivalents | 34.92 | 55.92 | 52.90 | 46.95 | 45.90 | 46.96 | 34.94 | 24.95 | 20.97 | 12.98 | 8.98 | 14.99 |
| Total Assets | 984 | 1,228 | 1,213 | 1,282 | 1,405 | 1,379 | 1,367 | 1,407 | 1,486 | 1,494 | 1,504 | 1,121 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 12.97 | 11.97 | 29.90 | 26.93 | 21.95 | 30.95 | 81.85 | 82.84 | 25.93 | 37.89 | 12.96 | 65.81 |
| Cash from investing activity | −156 | −109 | 6.02 | −21.05 | −86.23 | −3.01 | −12.04 | −43.13 | −29.11 | −50.14 | −59.19 | −39.11 |
| Cash from financing activity | 169 | 82.08 | −39.02 | −11.02 | 73.05 | −11.02 | −75.11 | −53.06 | 3.01 | 5.01 | 43.04 | −25.03 |
| Net cash flow | 26.88 | −14.94 | −1.99 | −4.98 | 7.97 | 16.93 | −3.98 | −12.96 | 0.00 | −7.97 | −2.99 | 1.99 |
| Capex | 215 | 147 | 49.18 | 77.28 | 116 | 47.20 | 28.09 | 43.18 | 57.19 | 81.34 | 54.18 | 59.25 |
| Free cash flow | −200 | −132 | −17.94 | −45.86 | −92.71 | −11.98 | 58.85 | 40.90 | −11.96 | −36.91 | −19.93 | 14.95 |
| CFO / OP % | 63.9% | 29.9% | 134.9% | 83.9% | 38.9% | 107.9% | 87.9% | 123.9% | 39.9% | 75.9% | 43.9% | 98.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 51 | 57 | 59 | 60 | 50 | 52 | 68 | 46 | 45 | 46 | 115 | 50 |
| Inventory days | 82 | 86 | 87 | 92 | 96 | 97 | 84 | 97 | 91 | 104 | 168 | 55 |
| Days payable | 66 | 53 | 77 | 84 | 74 | 85 | 77 | 80 | 75 | 82 | 155 | 70 |
| Cash conversion cycle | 68 | 89 | 69 | 68 | 71 | 64 | 75 | 63 | 61 | 68 | 127 | 34 |
| Working capital days | −6 | −7 | −4 | −7 | −1 | −6 | 17 | 18 | 9 | 10 | −7 | −13 |
| ROCE % | 1.0% | 1.0% | 1.0% | 3.0% | 2.0% | −1.0% | 4.0% | 4.0% | 1.0% | 1.0% | 1.0% | 6.0% |
For the Jun 2026 quarter, Kanoria Chemicals & Industries reported sales of ₹460 Cr, up 128.9% year on year and net profit of ₹25.90 Cr. The operating margin was 10.0%.
Kanoria Chemicals & Industries' sales for the year to Mar 2026 were ₹980 Cr; over the last twelve months they were ₹1,240 Cr.
Net profit for the year to Mar 2026 was ₹113 Cr, and ₹153 Cr over the last twelve months. Earnings per share over the same trailing period were ₹35.33.
Kanoria Chemicals & Industries reported borrowings of ₹292 Cr at Mar 2026, against cash and equivalents of ₹14.99 Cr.
Cash from operations was ₹65.81 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹14.95 Cr.